# Final Package From The Example Run

This is the manuscript package produced by the zero-to-one workflow. It is intentionally not marked submission-ready because the demo still contains missing statistics, unverified citations, and current journal-policy checks.

## Working Title Options

1. DRK1 Supports ABA-Induced Stomatal Closure in Arabidopsis Guard Cells
2. A Candidate Guard-Cell Kinase Contributes to the Full Stomatal Response to ABA
3. DRK1 Links ABA Responsiveness With ROS Accumulation During Stomatal Closure

Preferred title: option 1, because it is specific and evidence-bounded.

## Central Claim

DRK1 is required for the full ABA-induced stomatal closure response under the tested conditions, with associated effects on ABA-triggered ROS accumulation and selected ABA-responsive transcripts.

Do not claim yet:

- DRK1 directly regulates ABA signaling.
- DRK1 is the upstream regulator of ROS production.
- DRK1 defines a new ABA signaling mechanism.

## Figure Order

| Figure | Placement | Purpose | Linked Claims |
|---|---|---|---|
| F1 | Main | Establish the ABA stomatal aperture phenotype | C1 |
| F2 | Main | Link phenotype to DRK1 by complementation | C2 |
| F3 | Main | Connect phenotype to ABA-induced ROS response | C3 |
| F4 | Main or supplement | Add marker-gene support if quality is strong | C4 |

## Section Plan

| Section ID | Section | Purpose | Inputs Needed |
|---|---|---|---|
| SEC1 | Results 1 | Show the primary stomatal phenotype | F1, C1, statistics |
| SEC2 | Results 2 | Show complementation/rescue | F2, C2, genotype details |
| SEC3 | Results 3 | Show ROS-associated response | F3, C3, ABA-ROS citations |
| SEC4 | Results 4 | Present transcript marker evidence | F4, C4, marker-gene citations |
| SEC5 | Discussion | Bound the mechanistic interpretation | C1-C4, R1-R4 |

## Draft Abstract

Stomatal closure in response to abscisic acid (ABA) is central to plant water-stress responses, yet the regulatory factors that tune this response in guard cells remain incompletely defined [CITE: ABA guard-cell review]. Here, we evaluate the candidate kinase DRK1 in Arabidopsis guard-cell ABA responsiveness. ABA-treated drk1 mutants maintained larger stomatal apertures than wild-type plants, and this phenotype was partially restored by DRK1 complementation ([NEED: ABA concentration, time point, n, statistical test]). DRK1 disruption was also associated with reduced ABA-induced ROS accumulation and altered expression of selected ABA-responsive marker genes ([NEED: marker gene list]; [CITE: ABA-ROS pathway]). These results support a role for DRK1 in the full ABA-induced stomatal closure response while indicating that direct pathway placement requires additional mechanistic evidence. The study provides a bounded framework for testing DRK1-dependent guard-cell ABA signaling.

## Coached Results Paragraph

ABA treatment decreased stomatal aperture in wild-type plants, whereas drk1 mutants maintained a significantly larger aperture under the same treatment conditions ([NEED: ABA concentration, time point, n, statistical test]; Fig. 1). The partial restoration of this response in DRK1-complemented plants further links the phenotype to DRK1 disruption (Fig. 2). Together with the reduced ABA-induced ROS signal observed in drk1 guard cells (Fig. 3), these results support a role for DRK1 in the full guard-cell response to ABA, while leaving the precise pathway position to be resolved [CITE: ABA-ROS guard-cell pathway].

## Citation Audit

| Claim | Status | Needed Action |
|---|---|---|
| C1 | Needs statistics and background citations | Verify ABA assay details and cite ABA guard-cell background |
| C2 | Needs genotype/method detail | Confirm complementation construct and line information |
| C3 | Needs pathway citations | Cite verified ABA-induced ROS literature |
| C4 | Needs marker validation | Cite why selected genes are ABA-responsive markers |

## Submission Status

Final readiness: blocked.

Blocking tasks:

1. Verify current target-journal author instructions and article type requirements.
2. Add exact sample sizes, biological replicates, statistical tests, and P values.
3. Verify all citation metadata and replace `[CITE: ...]` placeholders.
4. Resolve whether direct pathway evidence can be added; otherwise keep bounded wording.
5. Complete data availability, funding, author contributions, conflict-of-interest, and methods details.

After these repairs, re-run `sci-reviewer-simulator`, `sci-citation-control`, and `sci-submission-revision` before submission.
